Balentine LLC’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-1,145
| Closed | -$318K | – | 575 |
|
2023
Q1 | $318K | Buy |
1,145
+141
| +14% | +$39.2K | 0.01% | 397 |
|
2022
Q4 | $278K | Buy |
1,004
+52
| +5% | +$14.4K | 0.01% | 454 |
|
2022
Q3 | $254K | Sell |
952
-987
| -51% | -$263K | 0.01% | 429 |
|
2022
Q2 | $395K | Buy |
1,939
+302
| +18% | +$61.5K | 0.01% | 365 |
|
2022
Q1 | $345K | Buy |
+1,637
| New | +$345K | 0.01% | 390 |
|
2020
Q3 | – | Sell |
-194
| Closed | -$52K | – | 229 |
|
2020
Q2 | $52K | Buy |
194
+122
| +169% | +$32.7K | ﹤0.01% | 236 |
|
2020
Q1 | $23K | Sell |
72
-132
| -65% | -$42.2K | ﹤0.01% | 253 |
|
2019
Q4 | $61K | Buy |
204
+166
| +437% | +$49.6K | ﹤0.01% | 164 |
|
2019
Q3 | $9K | Buy |
38
+11
| +41% | +$2.61K | ﹤0.01% | 356 |
|
2019
Q2 | $6K | Buy |
+27
| New | +$6K | ﹤0.01% | 435 |
|
2019
Q1 | – | Sell |
-158
| Closed | -$48K | – | 436 |
|
2018
Q4 | $48K | Hold |
158
| – | – | ﹤0.01% | 117 |
|
2018
Q3 | $56K | Buy |
+158
| New | +$56K | ﹤0.01% | 62 |
|
2018
Q1 | – | Sell |
-714
| Closed | -$227K | – | 114 |
|
2017
Q4 | $227K | Sell |
714
-1
| -0.1% | -$318 | 0.02% | 112 |
|
2017
Q3 | $224K | Buy |
715
+212
| +42% | +$66.4K | 0.02% | 106 |
|
2017
Q2 | $136K | Hold |
503
| – | – | 0.01% | 132 |
|
2017
Q1 | $138K | Sell |
503
-20
| -4% | -$5.49K | 0.01% | 131 |
|
2016
Q4 | $148K | Buy |
523
+83
| +19% | +$23.5K | 0.02% | 120 |
|
2016
Q3 | $138K | Buy |
440
+384
| +686% | +$120K | 0.02% | 104 |
|
2016
Q2 | $14K | Buy |
56
+37
| +195% | +$9.25K | ﹤0.01% | 288 |
|
2016
Q1 | $5K | Sell |
19
-4
| -17% | -$1.05K | ﹤0.01% | 302 |
|
2015
Q4 | $7K | Buy |
23
+6
| +35% | +$1.83K | ﹤0.01% | 362 |
|
2015
Q3 | $5K | Sell |
17
-168
| -91% | -$49.4K | ﹤0.01% | 403 |
|
2015
Q2 | $75K | Sell |
185
-84
| -31% | -$34.1K | 0.01% | 114 |
|
2015
Q1 | $114K | Buy |
+269
| New | +$114K | 0.02% | 85 |
|